Milestone Pharmaceuticals Inc. — All Filings
395 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001415889-25-016929 | Jun 12, 2025 | Jun 10, 2025 |
| 4 | — | 0001415889-25-016932 | Jun 12, 2025 | Jun 10, 2025 |
| 4 | — | 0001415889-25-016933 | Jun 12, 2025 | Jun 10, 2025 |
| 4 | — | 0001415889-25-016934 | Jun 12, 2025 | Jun 10, 2025 |
| 4 | — | 0001415889-25-016935 | Jun 12, 2025 | Jun 10, 2025 |
| 4 | — | 0001415889-25-016930 | Jun 12, 2025 | Jun 10, 2025 |
| 4 | — | 0001415889-25-016931 | Jun 12, 2025 | Jun 10, 2025 |
| 8-K | FORM 8-K | 0001104659-25-048160 | May 14, 2025 | — |
| 10-Q | 10-Q | 0001558370-25-007648 | May 14, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-042471 | Apr 30, 2025 | — |
| DEF 14A | DEF 14A | 0001104659-25-042640 | Apr 30, 2025 | Jun 10, 2025 |
| DEFA14A | DEFA14A | 0001104659-25-042642 | Apr 30, 2025 | — |
| ARS | ARS | 0001104659-25-042653 | Apr 30, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0002052113-25-000383 | Apr 22, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-029047 | Mar 28, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-025547 | Mar 19, 2025 | Mar 18, 2025 |
| 8-K | FORM 8-K | 0001104659-25-025055 | Mar 18, 2025 | — |
| 424B5 | 424B5 | 0001104659-25-025114 | Mar 18, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-023218 | Mar 13, 2025 | — |
| S-8 | FORM S-8 | 0001104659-25-023222 | Mar 13, 2025 | — |
| 10-K | 10-K | 0001558370-25-002849 | Mar 13, 2025 | Dec 31, 2024 |
| 8-K | FORM 8-K | 0001104659-25-016929 | Feb 25, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-020491 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0002012383-25-001168 | Feb 5, 2025 | — |
| 4 | — | 0001415889-25-002265 | Jan 29, 2025 | Jan 27, 2025 |
| 4 | — | 0001415889-25-002266 | Jan 29, 2025 | Jan 27, 2025 |
| 4 | — | 0001415889-25-002267 | Jan 29, 2025 | Jan 27, 2025 |
| 4 | — | 0001415889-25-002268 | Jan 29, 2025 | Jan 27, 2025 |
| 4 | — | 0001415889-25-002269 | Jan 29, 2025 | Jan 27, 2025 |
| EFFECT | — | 9999999995-24-003559 | Nov 22, 2024 | — |
| CORRESP | — | 0001104659-24-121087 | Nov 20, 2024 | — |
| UPLOAD | — | 0000000000-24-012753 | Nov 19, 2024 | — |
| 10-Q | 10-Q | 0001558370-24-015147 | Nov 12, 2024 | Sep 30, 2024 |
| 8-K | FORM 8-K | 0001104659-24-116493 | Nov 12, 2024 | — |
| S-8 | FORM S-8 | 0001104659-24-116855 | Nov 12, 2024 | — |
| S-3 | S-3 | 0001104659-24-116861 | Nov 12, 2024 | — |
| SC 13G/A | — | 0001319244-24-000053 | Oct 29, 2024 | — |
| 3 | — | 0001415889-24-022910 | Sep 5, 2024 | Sep 3, 2024 |
| 4 | — | 0001415889-24-022914 | Sep 5, 2024 | Sep 3, 2024 |
| 8-K | FORM 8-K | 0001104659-24-096648 | Sep 4, 2024 | Aug 28, 2024 |
| 4 | — | 0001415889-24-022532 | Aug 29, 2024 | Aug 28, 2024 |
| 4 | — | 0001415889-24-022535 | Aug 29, 2024 | Aug 28, 2024 |
| 4 | — | 0001415889-24-022533 | Aug 29, 2024 | Aug 28, 2024 |
| 4 | — | 0001415889-24-022534 | Aug 29, 2024 | Aug 28, 2024 |
| 4 | — | 0001415889-24-022536 | Aug 29, 2024 | Aug 28, 2024 |
| 4 | — | 0001415889-24-022537 | Aug 29, 2024 | Aug 28, 2024 |
| 8-K | FORM 8-K | 0001104659-24-087301 | Aug 8, 2024 | — |
| 10-Q | 10-Q | 0001558370-24-011603 | Aug 8, 2024 | Jun 30, 2024 |
| 3 | — | 0001415889-24-019662 | Jul 17, 2024 | Jul 15, 2024 |
| 4 | — | 0001415889-24-019664 | Jul 17, 2024 | Jul 15, 2024 |